MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Crossref DOI link: https://doi.org/10.1038/nrd.2016.246
Published Online: 2017-02-17
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rupaimoole, Rajesha
Slack, Frank J.
Text and Data Mining valid from 2017-02-17
Article History
First Online: 17 February 2017
Competing interests
: F.J.S is an adviser to Mirna Therapeutics and miRagen Therapeutics. R.R. declares no competing interests.